Pascal Brier, chief innovation officer at Capgemini, says the 2025 rise and deployment of artificial intelligence agents put enterprise AI progress on hold, but laid the ground for acceleration to ...

AI, in other words, did not erode critical thinking; it exposed how poorly we have been teaching it.

I was fascinated by the recent stories about the sudden ascension of Clawdbot, aka Moltbot, aka OpenClaw, driven by its capabilities and social media attention, marketed as “the AI that actually does ...

Today is a big day at the Milan Cortina Olympic Games, as the figure skating begins, curling and women’s hockey continue — ...

Merck (MRK) has ended discussions about a potential acquisition of biotech firm Revolution Medicines, The Wall Street Journal reported Sunday, citing people familiar with the situation. The ...

Jan 25 (Reuters) - Merck (MRK.N), opens new tab is no longer in discussions to buy cancer drug developer Revolution Medicines (RVMD.O), opens new tab, the Wall Street Journal reported on Sunday. The ...

The pause comes as Merck continues to evaluate external opportunities that could help reinforce its drug portfolio as it navigates upcoming patent expirations. The company has been seeking ...

Nearly 600 jobs have been lost after the owner of Revolution bars went into administration. The Revel Collective, which revealed on Monday that it had filed notice of an intention to appoint ...

Merck MRK2.71%increase; green up pointing triangle is no longer in discussions to buy biotech Revolution Medicines RVMD-0.13%decrease; red down pointing triangle, according to people familiar with the ...

Investing.com -- Merck & Company Inc (NYSE:MRK) has ceased discussions to acquire biotechnology firm Revolution Medicines Inc (NASDAQ:RVMD), following a failure to reach an agreement on the company’s ...

Giancarlo Esposito says it’s “time for a revolution” in the U.S. as political tensions rise with the actions of ICE agents in Minneapolis. “This is time for a revolution — and they don’t even know ...